N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 171 JPY -2.84% Market Closed
Market Cap: 7.4B JPY

Wall Street
Price Targets

Price Targets Summary
Noile-Immune Biotech Inc

Wall Street analysts forecast Noile-Immune Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Noile-Immune Biotech Inc is 448.8 JPY with a low forecast of 444.4 JPY and a high forecast of 462 JPY.

Lowest
Price Target
444.4 JPY
160% Upside
Average
Price Target
448.8 JPY
162% Upside
Highest
Price Target
462 JPY
170% Upside
Noile-Immune Biotech Inc Competitors:
Price Targets
4882
Perseus Proteomics Inc
94% Upside
300896
Imeik Technology Development Co Ltd
27% Upside
MRUS
Merus NV
62% Upside
TSVT
2Seventy Bio Inc
2% Upside
688293
Shanghai OPM Biosciences Co Ltd
34% Upside
ITOS
Iteos Therapeutics Inc
19% Upside
NTLA
Intellia Therapeutics Inc
377% Upside
251120
Bio-FD&C Co Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Noile-Immune Biotech Inc

For the last 3 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is -58%. The projected CAGR for the next 3 years is 249%.

-58%
Past Growth
249%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Noile-Immune Biotech Inc

Operating Income forecast
is not available for
Noile-Immune Biotech Inc

Net Income
Forecast

Net Income Estimate
Noile-Immune Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Noile-Immune Biotech Inc's stock price target?
Price Target
448.8 JPY

According to Wall Street analysts, the average 1-year price target for Noile-Immune Biotech Inc is 448.8 JPY with a low forecast of 444.4 JPY and a high forecast of 462 JPY.

What is Noile-Immune Biotech Inc's Revenue forecast?
Projected CAGR
249%

For the last 3 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is -58%. The projected CAGR for the next 3 years is 249%.

Back to Top